Amylyx Pharmaceuticals Inc (AMLX)

NASDAQ
38.75
+1.20(+3.20%)
After Hours
38.50
-0.23(-0.59%)
- Real-time Data
  • Volume:
    881,723
  • Day's Range:
    36.14 - 39.08
  • 52 wk Range:
    6.51 - 39.08
Trading near 52-week High

Amylyx Pharmaceuticals has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

AMLX Overview

Prev. Close
37.55
Day's Range
36.14-39.08
Revenue
345K
Open
37.61
52 wk Range
6.51-39.08
EPS
-4.2
Volume
881,723
Market Cap
2.32B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,590,352
P/E Ratio
-8.95
Beta
-
1-Year Change
-
Shares Outstanding
66,231,038
Next Earnings Date
Mar 29, 2023
What is your sentiment on Amylyx Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Amylyx Pharmaceuticals Inc News

Amylyx Pharmaceuticals Inc Analysis

Amylyx Pharmaceuticals Inc Company Profile

Amylyx Pharmaceuticals Inc Company Profile

Employees
226

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company’s product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyBuy
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Buy
  • 15 - 18 Monday
    0
    • 10.50
      0